Advancing Gene Therapy Innovation in Ophthalmology Trials

Ophthalmology gene therapy clinical trials differ from conventional ophthalmic drug studies because they target the genetic root cause of disease using single dose interventions delivered directly into ocular tissues, often with decade-long follow-up requirements and highly specialized imaging and functional endpoints. The post covers operational strategies for running complex ophthalmology gene therapy trials.